PublicacionesPublicaciones científicas y comunicaciones a congresos. Publicaciones científicas Comunicaciones a congresos ESMO ASCO Alberto Carral Maseda Marta Covela Rúa Sergio Vazquez-Estevez Jesús Mateos Martín Begoña Campos Balea Francisco Javier Casas Nebra SAPPHIRE Investigators. SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancerOct 20, 2023 | Publicaciones científicas, Sergio Vazquez-EstevezP-277 Real-world efficacy, safety, and impact of the GIPI score of nivolumab in advanced esophageal squamous cell carcinoma (ESCC) refractory or intolerant to prior chemotherapy in European population: The EPIC trialJul 1, 2023 | Alberto Carral Maseda, Comunicaciones a congresos, ESMO Entradas Siguientes »
SAPPHIRE Investigators. SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancerOct 20, 2023 | Publicaciones científicas, Sergio Vazquez-Estevez
P-277 Real-world efficacy, safety, and impact of the GIPI score of nivolumab in advanced esophageal squamous cell carcinoma (ESCC) refractory or intolerant to prior chemotherapy in European population: The EPIC trialJul 1, 2023 | Alberto Carral Maseda, Comunicaciones a congresos, ESMO
